RTOUX
Price
$50.45
Change
+$0.05 (+0.10%)
Updated
Jul 31 closing price
Net Assets
2.05B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

RTOUX vs VSCIX

RTOUX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
RTOUX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RTOUX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. RTOUX (2.05B). VSCIX pays higher dividends than RTOUX: VSCIX (1.23) vs RTOUX (0.49). RTOUX was incepted earlier than VSCIX: RTOUX (9 years) vs VSCIX (29 years). RTOUX (1.26) is less costly to investors than VSCIX (0.03). RTOUX is a more actively managed with annual turnover of: 55.00 vs. VSCIX (17.00). RTOUX has a lower initial minimum investment than VSCIX: RTOUX (0) vs VSCIX (5000000). RTOUX annual gain was more profitable for investors over the last year : 24.10 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. RTOUX (26.44).
RTOUXVSCIXRTOUX / VSCIX
Total Expense Ratio1.110.033,700%
Annual Report Gross Expense Ratio1.260.034,200%
Fund Existence9 years29 years-
Gain YTD15.84414.591109%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B189B1%
Annual Yield % from dividends0.491.2340%
Returns for 1 year24.1022.58107%
Returns for 3 years36.0743.4483%
Returns for 5 years26.4435.1375%
Returns for 10 yearsN/A156.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C